Standardized and flexible eight colour flow cytometry panels harmonized between different laboratories to study human NK cell phenotype and function-Reference-Cited by-同舟云学术

Standardized and flexible eight colour flow cytometry panels harmonized between different laboratories to study human NK cell phenotype and function

Published:2017-03-10 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Veluchamy John P.,Delso-Vallejo María,Kok Nina,Bohme Fenna,Seggewiss-Bernhardt Ruth,van der Vliet Hans J.,de Gruijl Tanja D.,Huppert Volker,Spanholtz Jan

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep43873.pdf

Reference50 articles.

1. O’Donnell, E. A., Ernst, D. N. & Hingorani, R. Multiparameter Flow Cytometry: Advances in High Resolution Analysis. Immune Network 13, 43–54, doi: 10.4110/in.2013.13.2.43 (2013).

2. Streitz, M. et al. Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study. Transplantation Research 2, 17–17, doi: 10.1186/2047-1440-2-17 (2013).

3. Hasan, M. et al. Semi-automated and standardized cytometric procedures for multi-panel and multi-parametric whole blood immunophenotyping. Clinical immunology (Orlando, Fla.) 157, 261–276, doi: 10.1016/j.clim.2014.12.008 (2015).

4. Rovati, B. et al. An eight-colour flow cytometric method for the detection of reference values of lymphocyte subsets in selected healthy donors. Clinical and Experimental Medicine 14, 249–259, doi: 10.1007/s10238-013-0239-4 (2014).

5. Kohrt, H. E. et al. Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials. Journal for immunotherapy of cancer 4, 15, doi: 10.1186/s40425-016-0118-0 (2016).

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Active juvenile systemic lupus erythematosus is associated with distinct NK cell transcriptional and phenotypic alterations;Scientific Reports;2024-06-06

2. Development and implementation of natural killer cell simultaneous ADCC and direct killing assay;Heliyon;2023-12

3. NK92 Expressing Anti-BCMA CAR and Secreted TRAIL for the Treatment of Multiple Myeloma: Preliminary In Vitro Assessment;Cells;2023-11-30

4. Novel Local “Off-the-Shelf” Immunotherapy for the Treatment of Myeloma Bone Disease;Cells;2023-01-30

5. Immunophenotyping: Analytical approaches and role in preclinical development of nanomedicines;Advanced Drug Delivery Reviews;2022-06